Display options
Cite
Waight PA, Andrews NJ, Ladhani NJ, et al. Effect of the 13-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in England and Wales 4 years after its introduction: an observational cohort study. Lancet Infect Dis. 2015;15(6):629doi: 10.1016/S1473-3099(15)00028-6.
Waight, P. A., Andrews, N. J., Ladhani, N. J., Sheppard, C. L., Slack, M. P., & Miller, E. (2015). Effect of the 13-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in England and Wales 4 years after its introduction: an observational cohort study. The Lancet. Infectious diseases, 15(6), 629. https://doi.org/10.1016/S1473-3099(15)00028-6
Waight, Pauline A, et al. "Effect of the 13-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in England and Wales 4 years after its introduction: an observational cohort study." The Lancet. Infectious diseases vol. 15,6 (2015): 629. doi: https://doi.org/10.1016/S1473-3099(15)00028-6
Waight PA, Andrews NJ, Ladhani NJ, Sheppard CL, Slack MP, Miller E. Effect of the 13-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in England and Wales 4 years after its introduction: an observational cohort study. Lancet Infect Dis. 2015 Jun;15(6):629. doi: 10.1016/S1473-3099(15)00028-6. Epub 2015 May 17. PMID: 26008826; PMCID: PMC7130081.
Copy Download .nbib Format: NLM
Share it on

Lancet Infect Dis. 2015 Jun;15(6):629. doi: 10.1016/S1473-3099(15)00028-6. Epub 2015 May 17.

Effect of the 13-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in England and Wales 4 years after its introduction: an observational cohort study.

The Lancet. Infectious diseases

Pauline A Waight, Nicholas J Andrews, Nicholas J Ladhani, Carmen L Sheppard, Mary P E Slack, Elizabeth Miller

PMID: 26008826 PMCID: PMC7130081 DOI: 10.1016/S1473-3099(15)00028-6

[No abstract available.]

Publication Types